NuChem Therapeutics Revenue and Competitors

Location

N/A

Total Funding

Chemicals

Industry

Estimated Revenue & Valuation

  • NuChem Therapeutics's estimated annual revenue is currently $7.5M per year.(i)
  • NuChem Therapeutics's estimated revenue per employee is $49,342

Employee Data

  • NuChem Therapeutics has 152 Employees.(i)
  • NuChem Therapeutics grew their employee count by 17% last year.

NuChem Therapeutics's People

NameTitleEmail/Phone
1
Director, BiologyReveal Email/Phone
2
ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$3.5M516%N/AN/A
#2
$15M332N/AN/AN/A
#3
$3.5M18-5%N/AN/A
#4
$3.5M20-29%N/AN/A
#5
N/A1949-7%N/AN/A
#6
$7.5M12220%N/AN/A
#7
$15M75-3%N/AN/A
#8
$15M1352%N/AN/A
#9
$15M191N/AN/AN/A
#10
N/A6N/AN/AN/A
Add Company

What Is NuChem Therapeutics?

NuChem Therapeutics is a Medicinal Chemistry contract research organization located in Montreal, Quebec, Canada. We offer a variety of services to support the biotech and pharmaceuticals industries to help identify and optimise pre-clinical candidates in the area of small molecule drug discovery. All members of our team have years of experience in preclinical drug discovery in the pharmaceutical industry (former Merck Frosst Canada scientists). We specialize in the art of medicinal chemistry and drug discovery biology and can provide custom synthesis of compounds, structure-activity-relationship (SAR) design, DMPK services, computational drug design and assay development to move your project forward quickly and efficiently. Our goal at NuChem Therapeutics is to become your first choice CRO partner by providing world class, cost-efficient and rapid-turnaround medicinal chemistry expertise with a strong customer focus.

keywords:N/A

N/A

Total Funding

152

Number of Employees

$7.5M

Revenue (est)

17%

Employee Growth %

N/A

Valuation

N/A

Accelerator

NuChem Therapeutics News

2019-03-25 - Global In-Vitro ADME Testing Services Market, 2018-2019 ...

... lead compound with therapeutic potential, play a crucial role in the overall success of a drug candidate in both preclinical and clinical studies.

2019-02-24 - AmorChem exits NuChem Therapeutics

CPE Media News (2/24/2019) – AmorChem L.P., an early stage life sciences venture capital fund, has sold NuChem Therapeutics Inc. to ...

2019-02-22 - Completion of a Successful Management Buyout Transaction ...

MONTREAL--(BUSINESS WIRE)--NuChem Therapeutics Inc., a drug discovery and development contract research organization (CRO) located ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$30.1M15226%N/A
#2
$35.1M1526%N/A
#3
$35.1M1529%N/A
#4
$34.5M153-11%N/A
#5
$45.4M1531%N/A